Systemic Immune-Inflammatory Index As a Predictor of Lymph Node Metastasis in Endometrial Cancer

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2022 Jan 7

PMID 34992410

Citations 19

Authors

Huifang Lei

Shuxia Xu

Xiaodan Mao

Xiaoying Chen

Yaojia Chen

Xiaoqi Sun

Pengming Sun

Affiliations

Soon will be listed here.

Abstract

Purpose: This study assessed the predictive value of the preoperative systemic immune-inflammatory index (SII) for lymph node metastasis (LNM) in endometrial cancer (EC) patients.

Methods: We retrospectively included 392 EC patients between January 2013 and January 2019. Data on clinical indicators including age, body mass index (BMI), menopause, serum inflammatory immune index, serum tumor markers, history of diabetes and hypertension, stage, histological type, and myometrial invasion (MI) were collected. The association between clinical indicators and LNM was evaluated.

Results: The results indicated that neutrophil (NE), monocyte (MO) counts, SII, cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 199 (CA199), and the expression of estrogen receptor (ER) and Ki67 were higher in EC patients with LNM than in those without LNM (P<0.05). Lymph vascular space invasion (LVSI) was also associated with LNM (P<0.05). Consequently, the SII, CA125, CA153 and LVSI were found to be independent risk factors for LNM, and a nomogram including these indicators was performed. The ROC curve analysis showed that compared with a single index, the combination of the SII, CA125, CA153 and LVSI significantly improved the efficiency of diagnosing LNM in EC patients (AUC=0.865, P < 0.001). Moreover, the SII was significantly associated with age, menopause, and FIGO stage (P < 0.05). Further logistic regression analysis suggested that elevated serum SII was an independent risk factor for MI and progression to a higher pathological grade in young premenopausal EC patients. In addition, elevated SII was an independent risk factor for advanced EC progression in age ≥55 or postmenopausal EC patients.

Conclusion: An elevated SII is an independent risk factor for LNM in patients with EC. In addition, the SII can be used as a predictor of MI and higher pathological grade in young premenopausal EC patients.

Citing Articles

Detecting the preoperative peripheral blood systemic immune-inflammation index (SII) as a tool for early diagnosis and prognosis of gallbladder cancer.

Liu F, Yin P, Jiao B, Shi Z, Qiao F, Xu J BMC Immunol. 2025; 26(1):7.

PMID: 39966731 PMC: 11834489. DOI: 10.1186/s12865-025-00683-x.

Association between neutrophil percentage to albumin ratio and short term prognosis of acute on chronic liver failure treated with artificial liver support system.

Ma Y, Du L, Bai L, Tang H Sci Rep. 2025; 15(1):5042.

PMID: 39934390 PMC: 11814120. DOI: 10.1038/s41598-025-89832-1.

Inverted U-shaped association between the systemic immune-inflammation index and colorectal polyps in Chinese patients: a cross-sectional study.

Bao J, Teng Y, Yang Y, Wang Q Front Med (Lausanne). 2025; 11:1515230.

PMID: 39931434 PMC: 11808360. DOI: 10.3389/fmed.2024.1515230.

Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C.

Ma Y, Wang J, Du L, Tang H Front Med (Lausanne). 2024; 11:1486503.

PMID: 39659620 PMC: 11628305. DOI: 10.3389/fmed.2024.1486503.

Preoperative prediction of lymph node metastasis in endometrial cancer patients via an intratumoral and peritumoral multiparameter MRI radiomics nomogram.

Yan B, Zhao T, Deng Y, Zhang Y Front Oncol. 2024; 14:1472892.

PMID: 39364314 PMC: 11446724. DOI: 10.3389/fonc.2024.1472892.

References

Aoyama T, Takano M, Miyamoto M, Yoshikawa T, Kato K, Sakamoto T . Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients. Oncology. 2019; 96(5):259-267. DOI: 10.1159/000497184. View

Todo Y, Sakuragi N . Methodological considerations in the analysis of the therapeutic significance of lymphadenectomy in endometrial cancer. Taiwan J Obstet Gynecol. 2013; 52(1):8-13. DOI: 10.1016/j.tjog.2013.01.003. View

Chen H, Wu Q, Zhang Y, Li Q, Ma J, Kong F . Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer. Gynecol Oncol. 2020; 158(3):689-697. DOI: 10.1016/j.ygyno.2020.05.040. View

Creasman W . Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009; 105(2):109. DOI: 10.1016/j.ijgo.2009.02.010. View

Hahn H, Lee I, Kim T, Lee K, Shim J, Kim J . Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol. 2013; 53(3):293-7. DOI: 10.1111/ajo.12089. View

Antonioli L, Blandizzi C, Pacher P, Hasko G . Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer. 2013; 13(12):842-57. DOI: 10.1038/nrc3613. View

Benedetti Panici P, Basile S, Maneschi F, Lissoni A, Signorelli M, Scambia G . Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100(23):1707-16. DOI: 10.1093/jnci/djn397. View

Jiang P, Huang Y, Tu Y, Li N, Kong W, Di F . Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma. Front Oncol. 2021; 11:682925. PMC: 8372407. DOI: 10.3389/fonc.2021.682925. View

Huang H, Liu Q, Zhu L, Zhang Y, Lu X, Wu Y . Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer. Sci Rep. 2019; 9(1):3284. PMC: 6397230. DOI: 10.1038/s41598-019-39150-0. View

10.

Sari M, Yalcin I, Sahin H, Meydanli M, Gungor T . Risk factors for paraaortic lymph node metastasis in endometrial cancer. Int J Clin Oncol. 2017; 22(5):937-944. DOI: 10.1007/s10147-017-1139-5. View

11.

Nithin K, Sridhar M, Srilatha K, Habebullah S . CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding. Afr Health Sci. 2019; 18(4):972-978. PMC: 6354887. DOI: 10.4314/ahs.v18i4.17. View

12.

Yang B, Shan B, Xue X, Wang H, Shan W, Ning C . Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models. PLoS One. 2016; 11(5):e0155145. PMC: 4862644. DOI: 10.1371/journal.pone.0155145. View

13.

Yokoi E, Mabuchi S, Komura N, Shimura K, Kuroda H, Kozasa K . The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations. Oncoimmunology. 2019; 8(12):e1662708. PMC: 6844305. DOI: 10.1080/2162402X.2019.1662708. View

14.

Li X, Xu Y, Zhang L . Serum CA153 as biomarker for cancer and noncancer diseases. Prog Mol Biol Transl Sci. 2019; 162:265-276. DOI: 10.1016/bs.pmbts.2019.01.005. View

15.

Lee J, Kong T, Paek J, Chang S, Ryu H . Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer. Int J Gynecol Cancer. 2016; 26(9):1630-1635. DOI: 10.1097/IGC.0000000000000820. View

16.

Cragun J, Havrilesky L, Calingaert B, Synan I, Secord A, Soper J . Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23(16):3668-75. DOI: 10.1200/JCO.2005.04.144. View

17.

Amant F, Mirza M, Koskas M, Creutzberg C . Cancer of the corpus uteri. Int J Gynaecol Obstet. 2018; 143 Suppl 2:37-50. DOI: 10.1002/ijgo.12612. View

18.

Matsubara S, Mabuchi S, Takeda Y, Kawahara N, Kobayashi H . Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer. PLoS One. 2021; 16(5):e0248871. PMC: 8121307. DOI: 10.1371/journal.pone.0248871. View

19.

Ferrone C, Dranoff G . Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010; 28(26):4045-51. PMC: 4872327. DOI: 10.1200/JCO.2010.27.9992. View

20.

Mahdi H, Jernigan A, Nutter B, Michener C, Rose P . Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion. J Gynecol Oncol. 2015; 26(3):208-13. PMC: 4510337. DOI: 10.3802/jgo.2015.26.3.208. View